SS Innovations International (NASDAQ:SSII) Stock Moved Down to “Sell” by Wall Street Zen

Wall Street Zen lowered shares of SS Innovations International (NASDAQ:SSII) from a hold rating to a sell rating in a report released on Saturday,Wall Street Zen reports.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of SS Innovations International in a research note on Thursday, October 15th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Sell” and a consensus target price of $7.00.

SS Innovations International Price Performance

Shares of NASDAQ:SSII traded up $0.34 during trading hours on Friday, hitting $1.66. 636,583 shares of the company’s stock traded hands, compared to its average volume of 83,453. SS Innovations International has a 1 year low of $1.26 and a 1 year high of $6.79. The business has a fifty day moving average price of $2.64 and a 200-day moving average price of $3.72. The firm has a market capitalization of $332.63 million, a P/E ratio of -27.67 and a beta of -1.52.

SS Innovations International (NASDAQ:SSII) last released its earnings results on Thursday, August 13th. The company reported ($0.01) EPS for the quarter. SS Innovations International had a negative net margin of 23.73% and a negative return on equity of 26.77%. The business had revenue of $13.94 million for the quarter.

Insider Buying and Selling at SS Innovations International

In other SS Innovations International news, CEO Srivastava Sudhir sold 33,333 shares of the company’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $3.00, for a total value of $99,999.00. Following the completion of the sale, the chief executive officer directly owned 108,520,928 shares in the company, valued at approximately $325,562,784. This represents a 0.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Hedge Funds Weigh In On SS Innovations International

Several institutional investors have recently made changes to their positions in the company. 71 West Capital Partners purchased a new position in SS Innovations International during the 3rd quarter valued at about $596,000. Inspire Investing LLC lifted its position in shares of SS Innovations International by 19.7% in the 3rd quarter. Inspire Investing LLC now owns 223,053 shares of the company’s stock worth $665,000 after purchasing an additional 36,756 shares during the period. Finally, Eversept Partners LP lifted its position in shares of SS Innovations International by 46.2% in the 1st quarter. Eversept Partners LP now owns 110,157 shares of the company’s stock worth $551,000 after purchasing an additional 34,799 shares during the period.

SS Innovations International Company Profile

SS Innovations International is a medical technology company focused on developing and manufacturing surgical robotic systems. Its flagship product, the SSI Mantra, is a multi-arm platform designed to support surgeons during minimally invasive procedures. The company’s offerings include surgical instruments and related technologies, such as its SSI Mudra instruments, as well as training and support services for hospitals and clinicians. The SSI Mantra system is designed with features including a surgeon console and 3D visualization, and the company has also emphasized remote surgery and telementoring capabilities.